Micro-RNA Expression Profiles in High Risk Prostate Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01220427|
Recruitment Status : Terminated
First Posted : October 13, 2010
Last Update Posted : March 3, 2016
|Condition or disease|
|Prostate Cancer Radical Prostatectomy|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Micro-RNA Expression Profiles in High Risk Prostate Cancer|
|Study Start Date :||June 2007|
|Clinical high-risk prostate cancer, radical prostatectomy|
- Recurrence free survival [ Time Frame: Yearly update until clinical progression ]The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.
- Cancer specific survival [ Time Frame: Yearly update until death ]The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly until death.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01220427
|Department of Urology and Pediatric Urology University Hospital Würzburg|
|Würzburg, Germany, 97080|